BioSpace News Archive

Stallergenes Greer announced its full year results for the year ended 31 December 2017.

Nature’s Rite now has its Bruise-Strain-Tear Repair™, Muscle Honey™ and Sleep Apnea Relief™ herbal remedies available to purchase on health and wellness e-commerce site RevNutrition.com.

BerGenBio ASA announces that the Company will be presenting an overview of the three ongoing phase II trials combining the Company’s selective AXL inhibitor bemcentinib with the anti-PD-1 therapy KEYTRUDA at the 3rd Annual Immuno-Oncology Summit Europe, London, UK, today at 10:05-10:35 GMT.

Orexo’s Annual Report for the 2017 fiscal year has been published and can be downloaded on the company’s website, www.orexo.com (investors/reports, presentations and audiocasts).

Alligator Bioscience announced that the Annual Report 2017 is available at the company website www.alligatorbioscience.com.

Clarivate Analytics announced today the launch of its annual “Drugs to Watch” report.

A new report from Navigant Research examines the emerging digital health industry, with a focus on how the Internet of Things (IoT) is disrupting healthcare and moving it to the home.

The ExSpiron is the first and only MV monitor capable of providing continuous, non-invasive measurements for individuals not on a ventilator.

The European Commission, acting on the positive recommendation from the European Medicines Agency (EMA) Committee for Orphan Medicinal Products, has granted orphan drug designation to the Company’s recombinant modified ricin toxin A-chain subunit (the active pharmaceutical ingredient in RiVax®) for the prevention of ricin poisoning.

Tilray Canada Ltd. announced that it has entered into a Letter of Intent (LOI) to become a preferred medical cannabis supplier to Pharmasave, the premier independent pharmacy banner in Canada.